Charles J. Casamento - Apr 1, 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Charles J. Casamento
Stock symbol
RLMD
Transactions as of
Apr 1, 2022
Transactions value $
-$510,048
Form type
4
Date filed
4/5/2022, 05:00 PM
Previous filing
Feb 28, 2022
Next filing
Oct 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Options Exercise $64.2K +19.8K $3.24 19.8K Apr 1, 2022 Direct
transaction RLMD Common Stock Sale -$95.7K -3.3K -16.67% $29.00 16.5K Apr 1, 2022 Direct F1
transaction RLMD Common Stock Sale -$95.7K -3.3K -20% $29.00 13.2K Apr 1, 2022 Direct F1
transaction RLMD Common Stock Sale -$95.7K -3.3K -25% $29.00 9.9K Apr 1, 2022 Direct F1
transaction RLMD Common Stock Sale -$95.7K -3.3K -33.33% $29.00 6.6K Apr 1, 2022 Direct F1
transaction RLMD Common Stock Sale -$95.7K -3.3K -50% $29.00 3.3K Apr 1, 2022 Direct F1
transaction RLMD Common Stock Sale -$95.7K -3.3K -100% $29.00 0 Apr 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Options Exercise $0 +19.8K +34.31% $0.00 77.5K Apr 1, 2022 Common Stock 19.8K $3.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
F2 The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..